Coronavirus (COVID-19): evaluation of submissions of diagnostic products
How the Department of Health and Social Care evaluates the submissions of commercially available COVID-19 diagnostic products.
Documents
Details
This document provides guidance on how the Department of Health and Social Care evaluates approaches from industry to encourage diagnostic and other scientific innovation.
Updates to this page
-
Added following bullet point under list of criteria on which a decision to progress to stage 2 of the rapid evaluation process is based: 'whether the product does or does not conform to any relevant published guidance'.
-
Updated contact information
-
Updated email address.
-
First published.